The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTreatt Regulatory News (TET)

Share Price Information for Treatt (TET)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 480.00
Bid: 480.00
Ask: 482.50
Change: 0.00 (0.00%)
Spread: 2.50 (0.521%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 480.00
TET Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Half Year Trading Update and Notice of Results

11 Apr 2022 07:00

RNS Number : 8727H
Treatt PLC
11 April 2022
 

11 April 2022

 

TREATT PLC

("Treatt" or "the Group")

 

Half Year Trading Update

and

Notice of Results

 

Good revenue growth continues; full year trading in line with expectations

 

Treatt, the manufacturer and supplier of a diverse and sustainable portfolio of natural extracts and ingredients for the beverage, flavour and fragrance industries, today publishes a trading update for the half year ended 31 March 2022 (the "Period").

 

Highlights

 

· Revenue grew by 9% (11% in constant currency) to £66.3m (H1 2021: £60.8m)

· Order book up in excess of 15%, with a particularly strong pipeline in healthier living, citrus and coffee categories

· As previously guided, a return to pre COVID-19 seasonality with operating profit H2 weighted

· Investment in skills and expertise across all levels of the business continues to support long-term growth

· Trading in line with the Board's expectations for the full year

 

Trading performance

 

The Board is pleased to confirm that revenue momentum has continued across the business. Expected revenue growth for the half year of 9% (11% in constant currency) has been driven by the Group's largest category, citrus, as the Group's renowned expertise and value-add solutions continued to demonstrate its strong market position in this market.

 

As previously guided, following an unusually strong H1 in FY21, driven by a shift in demand from on to off trade caused by COVID-19, FY22 has returned to more normal spring/summer beverage consumption seasonality; as a result both margins and profits are expected to be materially H2 weighted.

 

Revenue in synthetic aroma and herbs, spices & florals, being two of the Group's larger categories, grew strongly in the Period. Whilst good progress continued in the Group's higher margin healthier living categories of tea, health & wellness and fruit & vegetables, materially stronger performance is expected from these categories in H2, as evidenced by a good pipeline.

 

The Group continues to win new business with both new and existing customers through direct sales to global and local FMCG brands, as well as indirectly through the flavour and fragrance houses, demonstrating the strength of the Group's diverse business model. Further significant progress was also made with building out the Group's coffee platform which is focussed on the premium ready-to-drink and cold brew coffee markets, where we continue to see material growth in the opportunity pipeline.

 

The Group's investment in its substantial inventory holdings (equating to approximately six months trading) has helped the Group to successfully navigate various supply chain challenges. In addition the Group has decades of experience in managing movements in raw material prices which are impacted, not only by general inflation, but also by specific supply and demand factors such as climatic conditions. For example, in the Period orange oil prices continued to build to all-time highs, whereas lemon oil prices fell.

 

Our new UK facility is fully open for office-based employees as well as some of our R&D and technical teams. The operational commissioning continues apace and we are looking forward to most of our manufacturing being up and running by the middle of this calendar year. Thereafter will be a final phase of gradually transferring our most complex manufacturing activities to the new site by the middle of 2023. We believe this site, along with our recently expanded US facility, will provide Treatt with a much stronger platform to support its growth ambitions.

 

With the UK relocation nearing completion, and a strategic investment in inventory levels reflecting both higher orange oil prices and a strong order book, net debt at the end of the Period was approximately £20m.

 

The Group's hedging strategy is intended to mitigate the impact of long term exchange rate movements, which can mean fluctuations in the short term. During the Period there was a weakening of Sterling against the US Dollar and, as a result, the Board anticipates a net negative FX impact on the results for the Period of approximately £0.6m (H1 2021: £0.4m gain).

 

Outlook

 

H1 ended strongly and this momentum has continued into H2 with order books at record levels. With stronger growth coming through in H2 from the higher margin healthier living categories, the Group expects to deliver materially stronger margins in H2.

 

Notice of Results

 

Treatt's half year results for the six months ended 31 March 2022 will be announced on 10 May 2022 and the Group will also be hosting a Capital Markets Day on 27 May 2022. To register interest please contact MHP on the details below.

 

Daemmon Reeve, CEO, commented:

 

"After a record performance for the business last year, we've continued the momentum into the first half with a good sales performance, particularly driven by our largest category, citrus, where we have grown a number of longstanding relationships working with some of the biggest beverage companies.

 

"This year's performance is expected to reflect a reversion to more normalised beverage trends and overall trading continues in line with the Board's expectations. Despite the wider macro uncertainties, our second half pipeline is strong, we are bringing more of our new UK site into operation and we are seeing good opportunities across a number of categories, so remain confident for the future."

 

 

Enquiries:

Treatt plc +44 (0)1284 702500

Daemmon Reeve Chief Executive Officer

Richard Hope Chief Financial Officer

 

Joint Brokers

Investec Bank Plc +44 (0)20 7597 5970

Patrick Robb

David Anderson

 

Peel Hunt LLP +44 (0) 20 7418 8900

George Sellar

Andrew Clark

Lalit Bose

 

Financial PR

MHP Communications +44 (0) 20 3128 8789 / Treatt@mhpc.com 

Tim Rowntree

Simon Hockridge

Catherine Chapman

 

About the Group

Treatt is a global, independent manufacturer and supplier of a diverse and sustainable portfolio of natural extracts and ingredients for the flavour, fragrance and multinational consumer product industries, particularly in the beverage sector. Renowned for its technical expertise and knowledge of ingredients, their origins and market conditions, Treatt is recognised as a leader in its field.

 

The Group employs over 400 staff in Europe, North America and Asia and has manufacturing facilities in the UK and US. Its international footprint enables the Group to deliver powerful and integrated solutions for the food, beverage and fragrance industries across the globe.

 

 

For further information about the Group, visit www.treatt.com.

 

 

CAUTIONARY STATEMENT ABOUT FORWARD-LOOKING STATEMENTS

This announcement contains forward-looking statements that are subject to risk factors associated with, among other things, the economic and business circumstances occurring from time to time in the countries, sectors and markets in which the Group operates. It is believed that the expectations reflected in these statements are reasonable, but they may be affected by a wide range of variables which could cause actual results to differ materially from those currently anticipated. No assurances can be given that the forward-looking statements in this announcement will be realised. The forward-looking statements reflect the knowledge and information available at the date of preparation of this announcement and the Group undertakes no obligation to update these forward-looking statements. Nothing in this announcement should be construed as a profit forecast.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTGCGDSIXGDGDC
Date   Source Headline
30th Apr 20244:02 pmRNSVoting Rights and Capital
10th Apr 20247:00 amRNSHalf Year Trading Update & Notice of Results
19th Mar 20243:40 pmRNSNotification of Transactions of Directors
4th Mar 20247:00 amRNSAppointment of Chief Executive Officer
13th Feb 20249:35 amRNSHolding(s) in Company
31st Jan 20242:41 pmRNSNotification of Transaction of PDMR
25th Jan 20243:49 pmRNSResult of AGM
25th Jan 20247:00 amRNSAGM Trading Update
23rd Jan 20241:57 pmRNSTotal Voting Rights
21st Dec 20232:07 pmRNSNotification of Transaction of Director
15th Dec 20236:09 pmRNSNotification of Transactions - Replacement
15th Dec 20234:42 pmRNSNotification of Transactions of Directors
13th Dec 20237:00 amRNSInterim Chief Financial Officer Appointment
12th Dec 20234:24 pmRNSAnnual Report and Notice of Annual General Meeting
1st Dec 20237:01 amRNSBlock Listing Six Monthly Return
1st Dec 20237:00 amRNSBlock Listing Six Monthly Return
28th Nov 20234:15 pmRNS2023 Final Dividend
28th Nov 20237:00 amRNSFull Year Results
20th Oct 20237:00 amRNSCEO Succession
10th Oct 20237:00 amRNSTrading Update
18th Sep 20234:11 pmRNSHolding(s) in Company
15th Aug 20234:14 pmRNSNotification of Transactions of Directors
28th Jul 202310:43 amRNSTotal Voting Rights
13th Jul 202312:15 pmRNSReplacement - Director/PDMR Shareholding
13th Jul 202311:09 amRNSNotification of Transaction of Director
21st Jun 20234:05 pmRNSNotification of Transactions of Director
12th Jun 20234:13 pmRNSDirector Declaration
7th Jun 20232:28 pmRNSBlock Listing Application
1st Jun 20237:00 amRNSBlock listing Six Monthly Return
19th May 20235:10 pmRNSHolding(s) in Company
19th May 20234:28 pmRNSHolding(s) in Company
9th May 20237:00 amRNSHalf Year Results
12th Apr 20237:00 amRNSHalf Year Trading Update and Notice of Results
20th Mar 20233:28 pmRNSNotification of Transactions of Directors
7th Mar 20233:25 pmRNSDirector/PDMR Shareholding
22nd Feb 20233:06 pmRNSHolding(s) in Company
21st Feb 202312:51 pmRNSNotification of Transactions of Director
21st Feb 202312:49 pmRNSNotification of Transactions of Director
20th Feb 202311:01 amRNSNotification of Transaction of a Director
30th Jan 20231:49 pmRNSHolding(s) in Company
27th Jan 20233:10 pmRNSResult of AGM
27th Jan 20237:00 amRNSAGM Trading Update
10th Jan 20235:05 pmRNSVoting Rights and Capital
28th Dec 20227:00 amRNSNotification of Transaction of Director
28th Dec 20227:00 amRNSAnnual Report and Notice of Annual General Meeting
20th Dec 202212:20 pmRNSBoard Appointment and Board Committee Changes
16th Dec 20221:25 pmRNSNotification of Transactions of Directors
1st Dec 20223:55 pmRNSBLOCK LISTING SIX MONTHLY RETURN
1st Dec 20223:55 pmRNSBLOCK LISTING SIX MONTHLY RETURN
29th Nov 20224:36 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.